Streetbeat News

TNON

Tenon Medical, Inc.

https://www.tenonmed.com

Industry

Medical - Devices

Tenon Medical, Inc., a medical device company, develops surgical implant systems to optimize sacroiliac joint fixation/fusion surgery and corresponding outcomes. It sells The CATAMARAN SIJ Fusion System that includes instruments and implants designed to prepare and fixate the SI-Joint for fusion in the United States and Puerto Rico. The company was founded in 2012 and is based in Los Gatos, California.

Open

2.69

Mkt cap

8.5M

Volume

145K

High

2.77

P/E Ratio

-0.10

52-wk high

20.00

Low

2.61

Div yield

N/A

52-wk low

2.61

Tenon Medical has announced the second adjournment of its special meeting of stockholders, which is now scheduled for January 30, 2024. The reason for the adjournment or the agenda for the meeting has not been disclosed.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 10:03 pm

Tennon Medical's stock price has increased following the company's filing of a U.S. Patent Application for 'Systems For Sacroiliac (SI) Joint Stabilization'.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 8:21 pm

Tenon Medical has filed a U.S. patent application (No. 20230404762) for systems related to sacroiliac (SI) joint stabilization. The patent application is a significant step in the company's efforts to innovate in the medical device sector, specifically targeting treatments for conditions related to the SI joint.

Portfolio Pulse from Charles Gross

December 21, 2023 | 11:29 am

Tenon Medical, Inc. (NASDAQ:TNON) has announced its participation in two immersive webinar physician training programs featuring its Catamaran SI Joint Fusion System. The training, led by Dr. Matthew Davies, reached approximately 60 health care providers and focused on the system's clinical use, patient selection, procedural outcomes, and the advantages of the Catamaran Fixation Device. The company emphasizes its commitment to professional education and training for health care providers.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 1:34 pm

Genesco Inc. shares fell by approximately 20% following their quarterly results. The article also lists other stocks that moved significantly in Friday's mid-day session, categorizing them as gainers and losers. Notable gainers include Harbor Custom Development, Altimmune, and Elastic N.V., which rose due to positive trial results, financial results, and guidance, respectively. Among the losers, Polar Power experienced a significant drop after pricing a public offering, and Ampio Pharmaceuticals fell after a previous surge. The article provides a snapshot of the mid-day stock movements, highlighting the volatility and market reactions to company-specific news and broader market trends.

Portfolio Pulse from Lisa Levin

December 01, 2023 | 5:04 pm

Tenon Medical (NASDAQ:TNON) reported Q3 earnings with a loss of $(1.46) per share, outperforming the $(2.80) estimate, marking a 48.23% improvement from the previous year. However, sales of $944.00K fell short of the $1.07M estimate, despite being a 353.85% increase from the same period last year.

Portfolio Pulse from totan@benzinga.com

November 14, 2023 | 9:31 pm

During Tuesday's intraday session, several healthcare stocks experienced significant movements. Tenax Therapeutics (TENX) saw a massive increase of 319.0% to $0.65 with an exceptionally high trading volume. Tivic Health Systems (TIVC) rose by 68.89% following their Q3 earnings release. ZyVersa Therapeutics (ZVSA), INVO Bioscience (INVO), MSP Recovery (LIFW), and Tenon Medical (TNON) also saw gains ranging from 18.27% to 32.88%. On the downside, TC BioPharm (TCBP) plummeted by 90.0%, Aclaris Therapeutics (ACRS) dropped by 86.77%, and other stocks like Mainz Biomed (MYNZ), Verve Therapeutics (VERV), TRACON Pharma (TCON), and Alector (ALEC) experienced declines between 16.58% and 45.54%.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 5:31 pm

The article lists a number of companies scheduled to report their earnings on November 14, 2023. It includes their expected quarterly results, with some companies anticipated to report profits per share and others expected to report losses. The revenues for each company are also provided, giving investors insights into the financial performance of these companies for the upcoming earnings announcements.

Portfolio Pulse from Benzinga Insights

November 14, 2023 | 1:23 pm

During Monday's intraday session, several healthcare stocks experienced significant movements. Tenax Therapeutics (TENX) saw a massive surge of 322.1%, while Tivic Health Systems (TIVC) and ZyVersa Therapeutics (ZVSA) also posted substantial gains. On the downside, TC BioPharm (TCBP), Aclaris Therapeutics (ACRS), and Mainz Biomed (MYNZ) faced steep declines. Verve Therapeutics (VERV), TRACON Pharma (TCON), and Alector (ALEC) also dropped notably, with recent Q3 earnings reports potentially influencing their stock performance.

Portfolio Pulse from Benzinga Insights

November 13, 2023 | 5:31 pm

During Wednesday's intraday session, several healthcare stocks experienced significant movements. Heart Test Laboratories, Tenon Medical, Personalis, Cyclo Therapeutics, Viracta Therapeutics, and Senti Biosciences saw their stocks rise, with Heart Test Laboratories leading the gainers with a 60.5% increase. On the other hand, Durect, Establishment Labs Hldgs, Maravai LifeSciences, Panbela Therapeutics, PaxMedica, and Ontrak saw their stocks decline, with Durect leading the losers with a 76.4% decrease.

Portfolio Pulse from Benzinga Insights

November 08, 2023 | 5:31 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.